Previous Article |
Table of Contents
| Next Article
IMMUNOLOGY
Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity


Section on Immunology and Immunogenetics, Joslin Diabetes Center, and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, One Joslin Place, Boston, MA 02215
Contributed by Diane Mathis, March 24, 2004
In both human patients and murine models, the progression from insulitis to diabetes is neither immediate nor inevitable, as illustrated by the innocuous versus destructive infiltrates of BDC2.5 transgenic mice on the nonobese diabetic (NOD) versus C57BL/6.H-2g7 genetic backgrounds. Natural killer (NK)-cell-specific transcripts and the proportion of NK cells were increased in leukocytes from the aggressive BDC2.5/B6.H-2g7 lesions. NK cell participation was also enhanced in the aggressive lesions provoked by CTLA-4 blockade in BDC2.5/NOD mice. In this context, depletion of NK cells significantly inhibited diabetes development. NOD and B6.H-2g7 mice exhibit extensive variation in NK receptor expression, reminiscent of analogous human molecules. NK cells can be important players in type 1 diabetes, a role that was previously underappreciated.
type 1 diabetes | mouse model | microarray
* Present address: Genomics Institute, Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, CA 92121.
To whom correspondence may be addressed. E-mail: cbdm{at}joslin.harvard.edu or dm{at}joslin.harvard.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
R. Winkler-Pickett, H. A. Young, J. M. Cherry, J. Diehl, J. Wine, T. Back, W. E. Bere, A. T. Mason, and J. R. Ortaldo In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses J. Immunol., April 1, 2008; 180(7): 4495 - 4506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terme, N. Chaput, B. Combadiere, A. Ma, T. Ohteki, and L. Zitvogel Regulatory T Cells Control Dendritic Cell/NK Cell Cross-Talk in Lymph Nodes at the Steady State by Inhibiting CD4+ Self-Reactive T Cells J. Immunol., April 1, 2008; 180(7): 4679 - 4686. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Enzler, S. Gillessen, M. Dougan, J. P. Allison, D. Neuberg, D. A. Oble, M. Mihm, and G. Dranoff Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of {beta} cells Blood, August 1, 2007; 110(3): 954 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Inoue, T. Kaifu, A. Sugahara-Tobinai, A. Nakamura, J.-I. Miyazaki, and T. Takai Activating Fc{gamma} Receptors Participate in the Development of Autoimmune Diabetes in NOD Mice J. Immunol., July 15, 2007; 179(2): 764 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Holler, T. Yamagata, W. Jiang, M. Feuerer, C. Benoist, and D. Mathis The same genomic region conditions clonal deletion and clonal deviation to the CD8{alpha}{alpha} and regulatory T cell lineages in NOD versus C57BL/6 mice PNAS, April 24, 2007; 104(17): 7187 - 7192. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walzer, M. Blery, J. Chaix, N. Fuseri, L. Chasson, S. H. Robbins, S. Jaeger, P. Andre, L. Gauthier, L. Daniel, et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46 PNAS, February 27, 2007; 104(9): 3384 - 3389. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhou, H. Wei, and Z. Tian NK3-Like NK Cells Are Involved in Protective Effect of Polyinosinic-Polycytidylic Acid on Type 1 Diabetes in Nonobese Diabetic Mice J. Immunol., February 15, 2007; 178(4): 2141 - 2147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rodacki, B. Svoren, V. Butty, W. Besse, L. Laffel, C. Benoist, and D. Mathis Altered Natural Killer Cells in Type 1 Diabetic Patients Diabetes, January 1, 2007; 56(1): 177 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Huang, F.-D. Shi, S. Jung, G. C. Pien, J. Wang, T. P. Salazar-Mather, T. T. He, J. T. Weaver, H.-G. Ljunggren, C. A. Biron, et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system FASEB J, May 1, 2006; 20(7): 896 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Cirulli, J. Zalatan, M. McMaster, R. Prinsen, D. R. Salomon, C. Ricordi, B. E. Torbett, P. Meda, and L. Crisa The Class I HLA Repertoire of Pancreatic Islets Comprises the Nonclassical Class Ib Antigen HLA-G. Diabetes, May 1, 2006; 55(5): 1214 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liu, L. V. Kaer, A. L. Cava, M. Price, D. I. Campagnolo, M. Collins, D. A. Young, T. L. Vollmer, and F.-D. Shi Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease J. Immunol., May 1, 2006; 176(9): 5247 - 5254. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. BABAYA, M. NAKAYAMA, and G. S. EISENBARTH The Stages of Type 1A Diabetes Ann. N.Y. Acad. Sci., June 1, 2005; 1051(1): 194 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Bach, A. Bendelac, M. B. Brenner, H. Cantor, G. De Libero, M. Kronenberg, L. L. Lanier, D. H. Raulet, M. J. Shlomchik, and M. G. von Herrath The Role of Innate Immunity in Autoimmunity J. Exp. Med., December 20, 2004; 200(12): 1527 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hanna, P. Bechtel, Y. Zhai, F. Youssef, K. McLachlan, and O. Mandelboim Novel Insights on Human NK Cells' Immunological Modalities Revealed by Gene Expression Profiling J. Immunol., December 1, 2004; 173(11): 6547 - 6563. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Goldrath, C. J. Luckey, R. Park, C. Benoist, and D. Mathis The molecular program induced in T cells undergoing homeostatic proliferation PNAS, November 30, 2004; 101(48): 16885 - 16890. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, M. C. Rodriguez-Galan, J. J. Subleski, J. R. Ortaldo, D. L. Hodge, J.-M. Wang, O. Shimozato, D. A. Reynolds, and H. A. Young Peroxisome proliferator-activated receptor-{gamma} and its ligands attenuate biologic functions of human natural killer cells Blood, November 15, 2004; 104(10): 3276 - 3284. [Abstract] [Full Text] [PDF] |
||||